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erties of the questionnaire, but, due to VCP’s transversal design, the full process 
hasn’t been achieved.
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Objectives: The current prevalence of Multiple Sclerosis (MS) in Slovakia ranges 
from 100 till 150 cases per 100 000, actualized by 112 cases with insurance data. 
There are approx. 6 100 MS diagnosed MS patients. The objective of this paper was to 
find out all possible data about patients and for patients. MethOds: We conducted 
a research in collaboration with MS patient organizations. No HCP were involved, 
patient investigators were trained. A. Demography, treatment and socioeconomics 
(53 items), B. Specific questionnaire (31 items). We disseminated 500 questionnaires, 
356 valid questionnaires were at the end evaluated, 78% women, 20% men (2% n. a.), 
average age 48.5 ± 11.9 , range 23-78 y, median 49.5 y, 52% college/gymnasium, 24% 
university, equal w + m (p= 0.460). Results: First symptoms related to SM raised 
average in the age of 30.9 ± 9.2 y (median 30 y), 12% before the age of 20, 18% after 40 
, 41% were diagnosed until 6 months of the first visit by physician, another 21% in 
1 y. 30% were diagnosed after more than 2 y. 45% EDSS 4-6.5, 33% EDSS 0-3 and 16% 
EDSS 7-9.5 (6% did not announced), 60% impaired with walking, 10% wheelchair, 2% 
in bed, 51% with assistance by daily activities, 9% by any activity. With rising EDSS 
MS therapy declines and other therapy is rising. cOnclusiOns: The patients with 
MS in Slovakia, even with a relatively generous support from health care and social 
care and with available conventional or disease modifying therapy (DMT) suffer a 
significant decrease of their QoL.
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Objectives: Although psychometric properties of the Quality of Life InventoryTM 
(PedsQL) version 4.0 Generic Core Scales have been established in different pedi-
atric populations, it has not been validated in patients with functional consti-
pation (FC). The primary objective of the current study was to determine the 
reliability and validity of the Dutch translation of PedsQL in children with FC 
in The Netherlands. MethOds: The PedsQL was administered to 189 children 
and adolescents (aged 5-18 yrs) who met the Rome III diagnosis criteria for FC 
and 257 parents (of patients aged 2-18 yrs) recruited from 12 hospitals. Missing 
responses, internal consistency and reliability (Cronbach’s alpha), discriminant 
validity (t-test comparisons between children with FC and a separate sample of 
healthy children [from the literature]) and construct validity (Pearson correlation 
between a-priorihypothesized relationships between the PedsQL and disease-
specific indicators, including the GI-module and the Defecation Disorder List), and 
inter-rater reliability between self- and parent-reports (Intraclass Correlations 
Coefficients, ICC) were assessed. Results: The PedsQL showed minimal missing 
responses (5% child-, 0% parent-report) and achieved good to excellent internal 
consistency reliability for the Total Score (α 0.86 child, 0.88 parent), Physical Health 
Summary Score (α 0.75 child, 0.83 parent), and Psychosocial Health Summary 
Score (α 0.79 child, 0.85 parent). It also distinguished between healthy references 
and children with FC (d= 0.28-0.57 child, 0.49-0.85 parent). The PedsQL was cor-
related to disease-specific reference measures (r varied from 0.23 to 0.57 child, 
0.25 to 0.45 parent) consistent with the a-priori hypotheses. ICC’s between child 
and parent-reports ranged from 0.70 to 0.72. cOnclusiOns: The results showed 
good initial measurement properties of the Dutch version of the PedsQL generic 
core scales in patients with FC. It could be considered as a valuable tool for 
measuring health related quality of life in Dutch speaking patients aged 2 to 18 
years with FC.
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Objectives: To perform a pilot testing of the translated and culturally adapted 
Polish pre-final version of the DASH questionnaire in a population from a target 
setting. MethOds: Thirty patients (20 men), medium age 41.1 years (range 13 
-79) from Rehabilitation Centre STOCER (Konstancin-Jeziorna) took part in pilot 
testing. The studied population was heterogeneous in terms of side affected (right: 
13, left:13, both: 4), diagnosis (20 different diagnoses, most common - brachial 
plexus injury, n= 6) and treatment (both conservative and surgical). Subjects com-
pleted questionnaires and were asked if there were questions that were difficult to 
respond or difficult to understand. After that each patients had to explain in his/
her own words the meaning of five randomly chosen questions and their answers. 
We analyzed: number of missing items by question, number of missing items by 
patients and distribution of responses for each item. Results: Understanding of 
randomly chosen questions and answers was appropriate. All items, except one, 
had high frequency of present answers (86.7% - 100%). Item 21 (sexual activity) was 
omitted by 60% of respondents. Number of missing items by patients ranged from 
0 to 6. Five patients (16.7%) had more than 10 percent of the items left blank. Three 
from these persons were 60 years of age and over and could characterize with 
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Objectives: To examine the psychometric properties of the WHOQOL-OLD in 
Taiwan. MethOds: Five questionnaires including the WHOQOL-BREF, WHOQOL-
OLD, Geriatric Depression Scale (GDS-15), Barthel Index (BI), and Mini-Mental State 
Examination (MMSE) were used. A total of 524 participants (M = 76.2, SD = 7.5, 
ages ranged from 60 to 99) from northern and southern Taiwan completed these 
questionnaires. Cronbach’s alpha, correlation analysis, and factor analysis were 
conducted to examine internal consistency reliability, content validity, criterion 
validity, and construct validity. Results: Among the participants, 180 (34.4%) were 
male, and 344 (65.6%) were female. The results showed that the originally designed 
6-factor model of the WHOQOL-OLD was supported. Fit indices (CFI = 0.93, IFI = 
0.93, NNFI = 0.92 and RMSEA = 0.06) were acceptable. The internal consistency 
coefficients (Cronbach’s alpha) ranged from 0.72 to 0.95 for the 6 domains. Content 
validity coefficients were in the range of 0.41 to 0.80 for item-associated domain 
correlations. Except for the DAD domain (Death and dying), other domains showed 
moderate to high inter-domain correlations (Pearson’s correlation ranges from 0.24 
to 0.70) and provided good criterion related validity with GDS-15 and WHOQOL-BREF 
(Pearson’s correlation ranges from 0.23 to 0.55). cOnclusiOns: The results showed 
that the psychometric properties of WHOQOL-OLD were acceptable. The WHOQOL-
OLD module is a useful instrument for the old people in Taiwan.
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Objectives: The Asthma Control Questionnaire (ACQ) was developed and validated 
to measure the adequacy of asthma control in patients 11-70 years. Since younger 
children may have difficulty reading and understanding the instructions, questions 
and response options, an interviewer version (ACQ-IA) for 6-10 year old patients was 
developed and validated in UK English. If children had difficulty understanding an 
ACQ question, standardised alternative wording was added (in UK English, alterna-
tives were needed for questions 2-4 and 6). The objective was to develop the ACQ-IA 
in a further 11 languages [English (Australia), French (Belgium), Korean, Norwegian, 
Portuguese (Brazil, Portugal), Spanish (Argentina, Guatemala, Peru and the USA), 
and Swedish] based on the adult ACQ versions, using the methodology developed 
for the UK ACQ-IA. MethOds: First, the concept of each question was defined. For 
each language there was: (1) forward/backward translation of ACQ-IA instructions; 
(2) testing of instructions with interviewers; (3) Cognitive interviews with children 
(6-10yr) with symptomatic asthma (n= 5) to identify questions difficult to compre-
hend; (4) Development of alternative wording for these questions; (5) Testing of the 
alternatives on a different sample of children (n= 5). Results: In all languages at 
least three questions required alternative wording. Most frequently children had 
problems understanding medical terms such as “asthma,” “symptoms,” “wheeze,” 
and “short-acting bronchodilator.” “Asthma” was usually replaced by “difficulty in 
breathing” and “symptoms” was followed by examples in brackets (hard to breathe, 
cough, wheeze). For “wheeze”, “whistling sound when you breathe” was the most 
common alternative. Children usually know their “short-acting bronchodilator” as 
their “rescue” or “emergency” medicine. cOnclusiOns: Cognitive interviews with 
children were crucial for identifying ACQ questions difficult for 6-10 year olds to 
understand and for formulating the alternative wording in each language. The valid-
ity of this novel methodology for the ACQ-IA cultural adaptation has been further 
supported by these successful adaptations.
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Objectives: The aim of this study was to confirm the factorial structure of 
the short version of the CIVIQ questionnaire using Vein Consult Program (VCP) 
results. MethOds: The VCP was an international study aiming to evaluate the 
impact of chronic venous disease (CVD) on cost and quality of life. The factorial 
structure of CIVIQ-14 was evaluated using two methods: confirmatory factor 
analysis (CFA) and multitrait/multi-items matrix. CFA was performed based on the 
3-dimensional structure of CIVIQ-14 established in a previous study. 6 indices from 
CFA were used to assess stability: Chi², Root Mean Square Approximation (RMSEA), 
Adjusted Goodness-of-Fit Index (AGFI), Standardized Root Mean square Residual 
(SRMR), Normed-Fit Index (NFI) and Comparative-Fit Index (CFI). In addition, VCP 
results were also used to evaluate the psychometric properties of the questionnaire. 
Prior to data analysis, missing data were replaced using multiple imputation and 
a bootstrap was conduct to take the country-effect into account. Results: A total 
of 47149 questionnaires from 17 countries were available in the VCP, of which 1438 
were excluded for more than 50% missing values. Results from the CFA showed 
an acceptable adjustment of the CVIQ-14’s 3-dimensional structure to VCP data. 
Within absolute-fit indices, both AGFI and SRMR proved the model to be relevant 
(AGFI= 0.905; SRMR= 0.034) while RMSEA was slightly over threshold (RMSEA= 0.079; 
threshold= 0.07). Relative-fit indices were consistent with absolute indices, with 
NFI= 0.95 and CFI= 0.95. Multitrait/mutli-items analysis agreed with CFA, showing all 
items to be more correlated to their dimensions score, with correlation coefficient 
superior to 0.4. Evaluating psychometric properties of the scale, Cronbach’s alpha 
proved internal consistency (α > 0.8 in all dimension). cOnclusiOns: Confirmatory 
factor analysis on VCP data supported the stability of the CIVIQ-14 questionnaire 
factorial structure. An attempt has been made to evaluate the psychometric prop-
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should take caution when mapping EQ-5D values from algorithms that have not 
been externally validated, especially where these algorithms have used clinical 
outcomes or disease-specific measures of health-related quality of life. Our results 
suggest that mapping from generic outcome measures might be reasonable.
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Objectives: The Mini-International Neuropsychiatric Interview (M.I.N.I.) is a short, 
structured diagnostic interview, developed by psychiatrists and clinicians in the 
USA and Europe, for DSM-IV and ICD-10 psychiatric disorders. The objectives of our 
study were: 1) To determine if the psychiatric terms used in the M.I.N.I. are trans-
latable worldwide, especially in non-western countries, and 2) To review strategies 
used to culturally adapt psychiatric terms. MethOds: We reviewed the records 
of all linguistic validation projects involving the M.I.N.I. Results: We retrieved 
67 language versions, representing 47 countries. The analysis of the translations’ 
content revealed three types of results, depending on the existence (or not) of cor-
responding psychiatric terminology in the target languages. The standard meth-
odology (forward/backward and clinician review) was used in all countries and 
adapted, depending on the context. In all western and westernized countries (e.g., 
Europe, Russia, etc., totaling 49 languages), the psychiatric terms used in the M.I.N.I. 
were easily translated (i.e., existence of an agreed-upon corresponding terminol-
ogy). In languages where psychiatric terms do not exist (e.g., certain Sub-Saharan 
languages), all the clinician-directed parts (titles and clinician-directed instruc-
tions/algorithms), which are capitalized in the original instrument, were left in 
English, and the patient-directed parts were translated in the target languages. In 
languages where there is a partially agreed-upon terminology (e.g., Thai), the titles 
as well as the algorithms were translated with corresponding English equivalents 
between brackets, when necessary. Moreover, in order to follow the typographical 
conventions of the M.I.N.I., in languages with no capital letters (such as Kannada 
or Malayalam), the translations used bigger font size. cOnclusiOns: This review 
showed that terms used to describe psychiatric disorders had no equivalents in 
some countries, especially in Africa. Translation was not always possible and was 
even judged to be culturally and linguistically irrelevant in countries where psy-
chiatry is only taught in English.
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Objectives: Sawicki questionnaire is a 32-item specific measure for the evalu-
ation of the change in the measure of the Quality of Health Related Life (HRQOL) 
experienced by patients treated by Novel Oral Anticoagulants (NOACs) versus tra-
ditional Oral Anticoagulant Therapies (OAT). The objective of this research focuses 
on the application of the Rasch model in selecting the most appropriate items of 
Sawicki questionnaire. MethOds: Sample was composed of 689 Atrial Fibrillation 
(AF) patients in whom an attempt of electrical or pharmacological cardioversion 
was scheduled within a 4 months inclusion period from baseline (CARDIOVERSE 
study). Data were analyzed with WinSteps version 3.75 using the Rasch Partial 
Credit Model. Statistical criteria taken into account for the selection of those 
items with better psychometric properties were: model-fit and separation statis-
tics, Differential Item Functioning (DIF), unexpected responses and item content. 
The results were compared with those of the original version of the question-
naire in CARDIOVERSE sample. Results: Misfiting items were deleted, resulting in 
a 12 items version rated on a 4-point Likert-scale. This short form of the ques-
tionnaire showed good model fit and represented an accurate measure of the 
construct. Infit MNSQ ranged from 0.90 to 1.15 (M= 1.02; SD= 0.09) and outfit MNSQ 
ranged from 0.90 to 1.18 (M= 1.02; SD= 0.08). Person separation index and item 
reliability were 2.11 and 0.99 respectively and item-person map showed that the 
test was on-target and covered the wide range of the ability scale. Finally, the 
criterion validity of the short version by age, sex and risk groups was similar to 
the original version of the questionnaire. cOnclusiOns: Short version of Sawicki 
questionnaire has adequate psychometric properties in terms of goodness-of-
fit-test and reliability. This version makes it possible to have a new short and 
appropriate HRQoL measure for the study of the effect in QoL experienced by 
patients treated by NOACs.
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Objectives: To test convergent-discriminant validity of quality of life (QOL) 
impact attributions to arthritis and respiratory conditions using the multitrait-
multimethod (MTMM) approach. MethOds: Chronically-ill adults (N= 601) with 
osteoarthritis (OA) and respiratory (asthma, COPD) disease completed Internet-
based surveys. Ages ranged from 18-93 (median= 58), 66.5% female and 20.7% non-
white. QOL impact was measured using 3 methods: QOL Disease Impact Scale 
(QDIS) and disease severity with specific attribution to each condition, specific 
worse cognitive function. Fifteen items had responses with ≥ 35% frequency and 
three items (turning a key, recreational activities with force, recreational activities 
with moving arm freely) had responses with ≥ 50% frequency. cOnclusiOns: 
Patients had no complaints about understanding or difficulty of the adapted ver-
sion of the questionnaire. Still, there were some items with missing answers (most 
often - sexual activity). Although, we provide some evidence of content validity, 
additional testing for the retention of psychometric properties of the translated 
questionnaire is recommended.
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Objectives: For models that simulate patients over a long span, such as from birth 
to life expectancy, the baseline HRQoL can be incorporated. Typically this means 
that younger people have a higher utility than older people. The aim of this study 
was to investigate the impact of including age-specific baseline utilities in a model 
that simulated women at elevated risk of developing breast cancer from ages 20 to 
85. MethOds: A model was developed to evaluate the impact on costs and benefits 
of breast cancer surveillance in a population of women with a BRCA1 mutation. 
Women were modelled from age 20 to 85. QALY reductions were associated with the 
treatment of cancer and were stage-specific. The model was evaluated incorporat-
ing age-specific baseline QALYs and also where all ages had a baseline QALY of 1. 
The impact of age-specific baseline QALY inclusion was evaluated in terms of the 
ICERs for different surveillance strategies. Results: The incremental cost of each 
intervention and the interventions included in the cost-effectiveness efficiency 
frontier were unaffected by the choice of baseline HRQoL. However, both the average 
and incremental cost-effectiveness ratios were changed. For interventions on the 
cost-effectiveness efficiency frontier, all ICERs were less than € 100,000/QALY when 
age-specific baseline HRQoL values were used. ICERs reduced by an average € 11,520 
when a uniform baseline HRQoL was used. cOnclusiOns: The use of age-specific 
baseline HRQoL in a cost-effectiveness model needs to be carefully considered. 
Inclusion of age-specific baseline HRQoL can favour interventions with an impact 
at a younger age. Whether age-specific or uniform baseline data are used in a model, 
the alternative should be considered in a sensitivity analysis.
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Objectives: To estimate EQ-5D-5L crosswalk value set for Poland, based on 
Crosswalk methodology developed by EuroQol Group. MethOds: Based on the data 
from 3691 respondents from 6 European countries, EuroQol Group has developed 
a method of obtaining interim values sets for the EQ-5D-5L by means of map-
ping to the available EQ-5D-3L values sets (“crosswalk” methodology). A significant 
part of the data in this study came from Polish respondents (n= 972; 26.3%). Poland 
is the first Central European country with EQ-5D-3L time trade-off based social 
values set published. In order to obtain interim EQ-5D-5L values set, we applied 
Crosswalk methodology, developed by EuroQol Group, to available Polish EQ-5D-3L 
values set. Results: Estimated Polish values for 3125 EQ-5D-5L health states will 
be presented. Both, EQ-5D-5L and EQ-5D-3L values sets have the same range (from 
-0.523 to 1.000), but different means (0.448 vs. 0.380) and medians (0.483 vs. 0.403), 
respectively. Participation of states worse than dead is less in EQ-5D-5L (5.38%), 
than in EQ-5D-3L (13.17%) values set. cOnclusiOns: As long as value set based on 
preferences directly elicited from representative Polish general population sample 
is not available, estimated crosswalk values set should be used in EQ-5D-5L studies 
in Poland in order to calculate health state utilities.
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Objectives: Existing studies exploring the validity of using mapping algorithms 
to predict utilities in external datasets have found mixed results. We apply a series 
of published EQ-5D mapping algorithms to individual patient level data from a 
trial which in fact collected this outcome, with a view to assess the impact of 
using predicted versus actual EQ-5D values on the results of a cost-effectiveness 
model. MethOds: The RITA-3 trial compared early interventional strategy for 
patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) against 
a conservative strategy. EQ-5D data were collected at baseline, 4 months, 12 
months and yearly thereafter. A range of other clinical and quality of life out-
comes were also collected including the Seattle Angina Questionnaire (SAQ), 
SF-36 and the Canadian Cardiovascular Society (CCS) Functional Classification of 
Angina. Using mapping algorithms found in the published literature, we predicted 
EQ-5D scores using these outcome measures. We then explored what effect the 
predicted utilities had upon cost-effectiveness estimates in a model compared 
to those with the actual EQ-5D data. The comparisons were made across five 
patient subgroups. Results: The cost-effectiveness estimates varied according to 
the original outcome measure used to map and the patient subgroup. The EQ-5D 
values predicted using CCS scores produced cost-effectiveness estimates much 
higher than those with the actual EQ-5D data in the trial, whilst the estimates 
using EQ-5D values predicted using SAQ scores were lower. The values predicted 
using SF-36 scores gave cost-effectiveness estimates very similar to those with 
the EQ-5D data, irrespective of the patient subgroup. cOnclusiOns: Analysts 
